Dld Asset Management, LP Heron Therapeutics, Inc. Transaction History
Dld Asset Management, LP
- $632 Million
- Q1 2025
A detailed history of Dld Asset Management, LP transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Dld Asset Management, LP holds 193,500 shares of HRTX stock, worth $385,065. This represents 0.57% of its overall portfolio holdings.
Number of Shares
193,500Holding current value
$385,065% of portfolio
0.57%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding HRTX
# of Institutions
182Shares Held
125MCall Options Held
847KPut Options Held
47.7K-
Rubric Capital Management LP New York, NY26.7MShares$53.2 Million1.68% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$16.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$16.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$15.6 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13.9 Million26.51% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $236M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...